Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases.

Content Provider	Semantic Scholar
Author	Lu, Gongchen Wålen, A. I. Cheng, Qunli
Copyright Year	1997
Abstract	The aim of these studies was to explore the possibility that enhanced triacylglycerol clearance may contribute to the hypotriacylglycerolemic effect of n-3 fatty acids in humans. Healthy subjects (n = 20) and hypertriacylglycerolemic patients (n = 6) were given a placebo (olive oil, OO) or a fish-oil concentrate (FOC; 41% eicosapentaenoic acid and 23% docosahexaenoic acid) in two, independent, randomized, blind trials. For the healthy subjects, the FOC treatment period was 3 wk long and FOC intakes were 5 g/d. For the patients, treatment periods were 4 wk long and dosages were 5 g.70 kg body wt-1.d-1. Washout periods were 2-4 wk for both groups. Blood samples were drawn at the end of each phase and analyzed for plasma lipids, lipoproteins, and endogenous (nonheparin-stimulated) activities of lipoprotein lipase (LPL) and hepatic lipase (HL). In the healthy subjects the FOC decreased plasma triacylglycerol concentrations by 18% (P < 0.01), whereas in the patients concentrations were reduced by 35% (P < 0.05). Low-density-lipoprotein-cholesterol concentrations increased by 25% in the latter group (P = 0.06). FOC increased the endogenous activities of LPL and HL by 62% and 68%, respectively (P < 0.0001), in the healthy subjects, but only LPL in the patients (65%, P < 0.005). These data suggest that endogenous lipase activities may be altered by nutritional interventions, and further, that accelerated lipolysis could contribute, at least in part, to the observed effects of n-3 fatty acids on human lipoprotein metabolism.
File Format	PDF HTM / HTML
Alternate Webpage(s)	https://pdfs.semanticscholar.org/e561/807ecba15909b01f6c8a7b304d21fef2e360.pdf
Alternate Webpage(s)	https://watermark.silverchair.com/254.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAZ8wggGbBgkqhkiG9w0BBwagggGMMIIBiAIBADCCAYEGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMcRpjHDqvbNQEII4uAgEQgIIBUq3G6iGCmSVOOUh-VYoflU5wI2CGHxmuF29i0chCmzqjY0A841YyLtH75jTMIfbfNp9e8KzRj3KbpLLdl-OtW-_1wd68ZnzEPA7N5oP8kkKG0ZDXLD-9q4z5kIOP-iAQ1FiCbYC2RsUEDsZMcgzAaSImUJG4bR_FKjkBtqQngNMq8WaGKN063lCjnXWHsXUcwrhCy2PC_JQgRpM6PT46haQo1PEofbJWtOqaGPqyOiEV8IMJDE_wA701ziUmUvgc5yJkvKCxd66MPWcsx4XoNdAjrRdAglEFebN3Dl66VP7Agc79qFDUWSvzUr2nS4rYkNGUcFWkwCP1u0DJCdJi4nN1uGj3isF85kJHjzm-F9sTEALyBJJPJK0iivi190d3OGxwlCmzi63k2jCAKC30ryQuLmX4CR8BvOpAR87DPjdo_hXEYW5LgI5OaE9EAPHujTHo
Alternate Webpage(s)	http://ajcn.nutrition.org/content/66/2/254.full.pdf
PubMed reference number	9250102v1
Volume Number	66
Issue Number	2
Journal	The American journal of clinical nutrition
Language	English
Access Restriction	Open
Subject Keyword	CEV protocol Cholesterol Dosage Eicosapentaenoic Acid Fatty Liver LIPOPROTEIN LIPASE Lipolysis Lipoproteins Omega-3 Fatty Acids Patients Prognostic Nutritional Index (PNI) Triglycerides docosahexaenoic acid grams per day lipoprotein metabolism olive oil
Content Type	Text
Resource Type	Article